A 29-year-old woman, G2P1, presents to the labor and delivery unit at 39 weeks of gestation in active labor. She reports spontaneous rupture of membranes approximately 12 hours ago and has had mild intermittent contractions over the past 6 hours. Key History: Positive GBS screening at 36 weeks gestation. Stable maternal vitals, reassuring fetal heart rate. Cervical exam: 4 cm dilation, 80% effacement, -1 station. The obstetric team decides to initiate intrapartum GBS antibiotic prophylaxis due to her positive GBS status and prolonged rupture of membranes. What is the first-line antibiotic for intrapartum GBS prophylaxis?

A 32-year-old woman, G2P1, at 12 weeks gestation undergoes chorionic villus sampling (CVS) due to an increased risk of chromosomal abnormalities detected during her first-trimester ultrasound and screening tests. Findings: CVS Karyotype: Mosaic trisomy 16 in the placental sample, suggesting confined placental mosaicism (CPM). Amniocentesis: Fetal karyotype is normal (46,XX). Placental Tissue Analysis: Mosaicism for trisomy 21 confirmed. Which of the following outcomes is most likely in cases of confined placental mosaicism with a normal fetal karyotype?

A 32-year-old woman, gravida 2 para 1, at 12 weeks’ gestation is referred for chorionic villus sampling (CVS) due to an increased risk of chromosomal abnormalities noted during her first-trimester ultrasound and screening tests. She has no significant medical history and had a normal pregnancy with her first child. CVS Findings: Karyotype Results: Mosaic trisomy 16 detected in the placental sample. Interpretation: Confined placental mosaicism (CPM) suspected, but fetal involvement cannot be ruled out. What is the primary follow-up test to confirm whether the placental mosaicism detected on chorionic villus sampling (CVS) involves the fetus?